{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:26:50Z","timestamp":1788226010207,"version":"build-2803163510"},"reference-count":39,"publisher":"American Association for the Advancement of Science (AAAS)","content-domain":{"domain":["spj.science.org"],"crossmark-restriction":true},"short-container-title":["Research"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:p>Primary sclerosing cholangitis (PSC) is a biliary disease accompanied by chronic inflammation of the liver and biliary stricture. Mesenchymal stem cells (MSCs) are used to treat liver diseases because of their immune regulation and regeneration-promoting functions. This study was performed to explore the therapeutic potential of human placental MSCs (hP-MSCs) in PSC through the Takeda G protein-coupled receptor 5 (TGR5) receptor pathway. Liver tissues were collected from patients with PSC and healthy donors (<jats:italic>n<\/jats:italic>\u00a0=\u00a04) for RNA sequencing and intrahepatic cholangiocyte organoid construction. hP-MSCs were injected via the tail vein into Mdr2<jats:sup>\u2212\/\u2212<\/jats:sup>, bile duct ligation (BDL), and 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) mouse models or co-cultured with organoids to confirm their therapeutic effect on biliary cholangitis. Changes in bile acid metabolic profile were analyzed by liquid chromatography\/tandem mass spectrometry (LC-MS\/MS). Compared with healthy controls, liver tissues and intrahepatic cholangiocyte organoids from PSC patients were characterized by inflammation and cholestasis, and marked downregulation of bile acid receptor TGR5 expression. hP-MSC treatment apparently reduced the inflammation, cholestasis, and fibrosis in Mdr2<jats:sup>\u2212\/\u2212<\/jats:sup>, BDL, and DDC model mice. By activating the phosphatidylinositol 3 kinase\/extracellular signal-regulated protein kinase pathway, hP-MSC treatment promoted the proliferation of cholangiocytes, and affected the transcription of downstream nuclear factor \u03baB through regulation of the binding of TGR5 and Pellino3, thereby affecting the cholangiocyte inflammatory phenotype.<\/jats:p>","DOI":"10.34133\/research.0207","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T11:32:36Z","timestamp":1690889556000},"update-policy":"https:\/\/doi.org\/10.34133\/aaas_crossmark_01","source":"Crossref","is-referenced-by-count":27,"title":["Human Placental Mesenchymal Stem Cells Relieve Primary Sclerosing Cholangitis via Upregulation of TGR5 in Mdr2<sup>\u2212\/\u2212<\/sup>Mice and Human Intrahepatic Cholangiocyte Organoid Models"],"prefix":"10.34133","volume":"6","author":[{"given":"Qigu","family":"Yao","sequence":"first","affiliation":[{"name":"State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou 310003, China."},{"name":"National Clinical Research Center for Infectious Diseases, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou 310003, China."},{"name":"National Clinical Research Center for Infectious Diseases, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingduo","family":"Yu","sequence":"additional","affiliation":[{"name":"State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou 310003, China."},{"name":"National Clinical Research Center for Infectious Diseases, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiqiong","family":"Gao","sequence":"additional","affiliation":[{"name":"State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou 310003, China."},{"name":"National Clinical Research Center for Infectious Diseases, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahang","family":"Zhou","sequence":"additional","affiliation":[{"name":"State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou 310003, China."},{"name":"National Clinical Research Center for Infectious Diseases, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[{"name":"State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou 310003, China."},{"name":"National Clinical Research Center for Infectious Diseases, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Pan","sequence":"additional","affiliation":[{"name":"State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou 310003, China."},{"name":"National Clinical Research Center for Infectious Diseases, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou 310003, China."},{"name":"National Clinical Research Center for Infectious Diseases, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Zhou","sequence":"additional","affiliation":[{"name":"State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou 310003, China."},{"name":"National Clinical Research Center for Infectious Diseases, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong","family":"Yu","sequence":"additional","affiliation":[{"name":"State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou 310003, China."},{"name":"National Clinical Research Center for Infectious Diseases, Hangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6604-6867","authenticated-orcid":true,"given":"Hongcui","family":"Cao","sequence":"additional","affiliation":[{"name":"State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou 310003, China."},{"name":"National Clinical Research Center for Infectious Diseases, Hangzhou, China."},{"name":"Key Laboratory of Diagnosis and Treatment of Aging and Physic-chemical Injury Diseases of Zhejiang Province, 79 Qingchun Rd., Hangzhou 310003, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanjuan","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory for the Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Rd., Hangzhou 310003, China."},{"name":"National Clinical Research Center for Infectious Diseases, Hangzhou, China."},{"name":"Jinan Microecological Biomedicine Shandong Laboratory, Jinan 250117, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"issue":"10139","key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson J","year":"2018","unstructured":"Dyson J, Beuers U, Jones D, Lohse A, Hudson M. Primary sclerosing cholangitis. Lancet. 2018;391(10139):2547\u20132559.","journal-title":"Lancet"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.154"},{"issue":"11","key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata Y","year":"2003","unstructured":"Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, Miwa M, Fukusumi S, Habata Y, Itoh T, Shintani Y, et al. A G protein-coupled receptor responsive to bile acids. J Biol Chem. 2003;278(11):9435\u20139440.","journal-title":"J Biol Chem"},{"issue":"1","key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000324138","article-title":"TGR5 sequence variation in primary sclerosing cholangitis","volume":"29","author":"Hov J","year":"2011","unstructured":"Hov J, Keitel V, Schrumpf E, H\u00e4ussinger D, Karlsen T. TGR5 sequence variation in primary sclerosing cholangitis. Dig Dis. 2011;29(1):78\u201384.","journal-title":"Dig Dis"},{"issue":"3","key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1478-3231.2011.02607.x","article-title":"Evolving concepts in primary sclerosing cholangitis","volume":"32","author":"Krones E","year":"2012","unstructured":"Krones E, Graziadei I, Trauner M, Fickert P. Evolving concepts in primary sclerosing cholangitis. Liver Int. 2012;32(3):352\u2013369.","journal-title":"Liver Int"},{"issue":"1","key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/gutjnl-2018-316975","article-title":"TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function","volume":"69","author":"Merlen G","year":"2020","unstructured":"Merlen G, Kahale N, Ursic-Bedoya J, Bidault-Jourdainne V, Simerabet H, Doignon I, Tanfin Z, Garcin I, P\u00e9an N, Gautherot J, et al. TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function. Gut. 2020;69(1):146\u2013157.","journal-title":"Gut"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309458"},{"issue":"3","key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.30470","article-title":"Bile-derived organoids from patients with primary sclerosing cholangitis recapitulate their inflammatory immune profile","volume":"70","author":"Soroka C","year":"2019","unstructured":"Soroka C, Assis D, Alrabadi L, Roberts S, Cusack L, Jaffe A, Boyer J. Bile-derived organoids from patients with primary sclerosing cholangitis recapitulate their inflammatory immune profile. Hepatology. 2019;70(3):871\u2013882.","journal-title":"Hepatology"},{"issue":"7","key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.cgh.2019.12.013","article-title":"Great expectations: Can magnetic resonance elastography accelerate progress in primary sclerosing cholangitis research?","volume":"18","author":"Bashir MR","year":"2020","unstructured":"Bashir MR, Muir AJ. Great expectations: Can magnetic resonance elastography accelerate progress in primary sclerosing cholangitis research? Clin Gastroenterol Hepatol. 2020;18(7):1436\u20131438.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0064-x"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2017.11"},{"issue":"1","key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s13287-022-02953-6","article-title":"Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): Safety profile assessment","volume":"13","author":"Aghayan H","year":"2022","unstructured":"Aghayan H, Salimian F, Abedini A, Fattah Ghazi S, Yunesian M, Alavi-Moghadam S, Makarem J, Majidzadeh-A K, Hatamkhani A, Moghri M, et al. Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): Safety profile assessment. Stem Cell Res Ther. 2022;13(1):365.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41419-022-04708-w","article-title":"Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury","volume":"13","author":"Lin F","year":"2022","unstructured":"Lin F, Chen W, Zhou J, Zhu J, Yao Q, Feng B, Feng X, Shi X, Pan Q, Yu J, et al. Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury. Cell Death Dis. 2022;13(3):271.","journal-title":"Cell Death Dis"},{"issue":"1","key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1186\/s13287-021-02616-y","article-title":"Activation of the EGFR-PI3K-CaM pathway by PRL-1-overexpressing placenta-derived mesenchymal stem cells ameliorates liver cirrhosis via ER stress-dependent calcium","volume":"12","author":"Kim S","year":"2021","unstructured":"Kim S, Kim J, Park S, Jeong W, Kim J, Bae S, Kim G. Activation of the EGFR-PI3K-CaM pathway by PRL-1-overexpressing placenta-derived mesenchymal stem cells ameliorates liver cirrhosis via ER stress-dependent calcium. Stem Cell Res Ther. 2021;12(1):551.","journal-title":"Stem Cell Res Ther"},{"issue":"22","key":"e_1_3_4_16_2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228874","article-title":"Administration of Human MSC-derived extracellular vesicles for the treatment of primary sclerosing cholangitis: Preclinical data in MDR2 knockout mice","volume":"21","author":"Angioni R","year":"2020","unstructured":"Angioni R, Cal\u00ec B, Vigneswara V, Crescenzi M, Merino A, S\u00e1nchez-Rodr\u00edguez R, Liboni C, Hoogduijn M, Newsome P, Muraca M, et al. Administration of Human MSC-derived extracellular vesicles for the treatment of primary sclerosing cholangitis: Preclinical data in MDR2 knockout mice. Int J Mol Sci. 2020;21(22).","journal-title":"Int J Mol Sci"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-324305"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.bbadis.2017.08.021","article-title":"Bile acid receptors in the biliary tree: TGR5 in physiology and disease","volume":"1864","author":"Deutschmann K","year":"2018","unstructured":"Deutschmann K, Reich M, Klindt C, Dr\u00f6ge C, Spomer L, H\u00e4ussinger D, Keitel V. Bile acid receptors in the biliary tree: TGR5 in physiology and disease. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1319\u20131325.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"11","key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"G1013","DOI":"10.1152\/ajpgi.00383.2012","article-title":"Ciliary subcellular localization of TGR5 determines the cholangiocyte functional response to bile acid signaling","volume":"304","author":"Masyuk A","year":"2013","unstructured":"Masyuk A, Huang B, Radtke B, Gajdos G, Splinter P, Masyuk T, Gradilone S, LaRusso N. Ciliary subcellular localization of TGR5 determines the cholangiocyte functional response to bile acid signaling. Am J Physiol Gastrointest Liver Physiol. 2013;304(11):G1013\u2013G1024.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-0038-1669940","article-title":"Role of TGR5 (GPBAR1) in liver disease","volume":"38","author":"Keitel V","year":"2018","unstructured":"Keitel V, H\u00e4ussinger D. Role of TGR5 (GPBAR1) in liver disease. Semin Liver Dis. 2018;38(4):333\u2013339.","journal-title":"Semin Liver Dis"},{"issue":"1","key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbrc.2008.04.171","article-title":"Expression and function of the bile acid receptor TGR5 in Kupffer cells","volume":"372","author":"Keitel V","year":"2008","unstructured":"Keitel V, Donner M, Winandy S, Kubitz R, H\u00e4ussinger D. Expression and function of the bile acid receptor TGR5 in Kupffer cells. Biochem Biophys Res Commun. 2008;372(1):78\u201384.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/s41598-020-58562-x","article-title":"Obeticholic acid and INT-767 modulate collagen deposition in a NASH in\u00a0vitro model","volume":"10","author":"Anfuso B","year":"2020","unstructured":"Anfuso B, Tiribelli C, Adorini L, Rosso N. Obeticholic acid and INT-767 modulate collagen deposition in a NASH in\u00a0vitro model. Sci Rep. 2020;10(1):1699.","journal-title":"Sci Rep"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/164_2019_230","article-title":"Bile acid-activated receptors: GPBAR1 (TGR5) and other G protein-coupled receptors","volume":"256","author":"Keitel V","year":"2019","unstructured":"Keitel V, Stindt J, H\u00e4ussinger D. Bile acid-activated receptors: GPBAR1 (TGR5) and other G protein-coupled receptors. Handb Exp Pharmacol. 2019;256:19\u201349.","journal-title":"Handb Exp Pharmacol"},{"issue":"3","key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2021.03.029","article-title":"Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis","volume":"75","author":"Reich M","year":"2021","unstructured":"Reich M, Spomer L, Klindt C, Fuchs K, Stindt J, Deutschmann K, H\u00f6hne J, Liaskou E, Hov J, Karlsen T, et al. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis. J Hepatol. 2021;75(3):634\u2013646.","journal-title":"J Hepatol"},{"issue":"2","key":"e_1_3_4_25_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2020.100214","article-title":"TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload","volume":"3","author":"Bidault-Jourdainne V","year":"2021","unstructured":"Bidault-Jourdainne V, Merlen G, Gl\u00e9nisson M, Doignon I, Garcin I, P\u00e9an N, Boisgard R, Ursic-Bedoya J, Serino M, Ullmer C, et al. TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload. JHEP Rep. 2021;3(2): 100214.","journal-title":"JHEP Rep"},{"issue":"19","key":"e_1_3_4_26_2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910858","article-title":"Flaxseed powder attenuates non-alcoholic steatohepatitis via modulation of gut microbiota and bile acid metabolism through gut-liver axis","volume":"22","author":"Yang C","year":"2021","unstructured":"Yang C, Wan M, Xu D, Pan D, Xia H, Yang L, Sun G. Flaxseed powder attenuates non-alcoholic steatohepatitis via modulation of gut microbiota and bile acid metabolism through gut-liver axis. Int J Mol Sci. 2021;22(19).","journal-title":"Int J Mol Sci"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32107"},{"issue":"1","key":"e_1_3_4_28_2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13045-022-01240-4","article-title":"Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: A multicenter, randomized, phase 3, open-label trial","volume":"15","author":"Zhao K","year":"2022","unstructured":"Zhao K, Lin R, Fan Z, Chen X, Wang Y, Huang F, Xu N, Zhang X, Zhang X, Xuan L, et al. Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: A multicenter, randomized, phase 3, open-label trial. J Hematol Oncol. 2022;15(1):22.","journal-title":"J Hematol Oncol"},{"issue":"3","key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/ecco-jcc\/jjab154","article-title":"Mesenchymal stem cell injection in Crohn's disease strictures: A phase I-II clinical study","volume":"16","author":"Vieujean S","year":"2022","unstructured":"Vieujean S, Loly J, Boutaffala L, Meunier P, Reenaers C, Briquet A, Lechanteur C, Baudoux E, Beguin Y, Louis E. Mesenchymal stem cell injection in Crohn's disease strictures: A phase I-II clinical study. J Crohns Colitis. 2022;16(3):506\u2013510.","journal-title":"J Crohns Colitis"},{"issue":"8","key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1136\/annrheumdis-2017-211073","article-title":"A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis","volume":"76","author":"Deng D","year":"2017","unstructured":"Deng D, Zhang P, Guo Y, Lim T. A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis. Ann Rheum Dis. 2017;76(8):1436\u20131439.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/path.5228","article-title":"High-throughput sequencing identifies aetiology-dependent differences in ductular reaction in human chronic liver disease","volume":"248","author":"Govaere O","year":"2019","unstructured":"Govaere O, Cockell S, Van Haele M, Wouters J, Van Delm W, Van den Eynde K, Bianchi A, van Eijsden R, Van Steenbergen W, Monbaliu D, et al. High-throughput sequencing identifies aetiology-dependent differences in ductular reaction in human chronic liver disease. J Pathol. 2019;248(1):66\u201376.","journal-title":"J Pathol"},{"issue":"6","key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2017.01.019","article-title":"Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis","volume":"66","author":"Vesterhus M","year":"2017","unstructured":"Vesterhus M, Holm A, Hov J, Nyg\u00e5rd S, Schrumpf E, Melum E, Thorbj\u00f8rnsen L, Paulsen V, Lundin K, Dale I, et al. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis. J Hepatol. 2017;66(6):1214\u20131222.","journal-title":"J Hepatol"},{"issue":"1","key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12974-021-02087-1","article-title":"TGR5 activation attenuates neuroinflammation via Pellino3 inhibition of caspase-8\/NLRP3 after middle cerebral artery occlusion in rats","volume":"18","author":"Liang H","year":"2021","unstructured":"Liang H, Matei N, McBride D, Xu Y, Zhou Z, Tang J, Luo B, Zhang J. TGR5 activation attenuates neuroinflammation via Pellino3 inhibition of caspase-8\/NLRP3 after middle cerebral artery occlusion in rats. J Neuroinflammation. 2021;18(1):40.","journal-title":"J Neuroinflammation"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.11.013"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8833467","article-title":"Antioxidative capacity of liver- and adipose-derived mesenchymal stem cell-conditioned media and their applicability in treatment of type 2 diabetic rats","volume":"2021","author":"Elshemy M","year":"2021","unstructured":"Elshemy M, Asem M, Allemailem K, Uto K, Ebara M, Nabil A. Antioxidative capacity of liver- and adipose-derived mesenchymal stem cell-conditioned media and their applicability in treatment of type 2 diabetic rats. Oxidative Med Cell Longev. 2021;2021: 8833467.","journal-title":"Oxidative Med Cell Longev"},{"issue":"1","key":"e_1_3_4_36_2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13287-019-1136-x","article-title":"Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism","volume":"10","author":"Ling L","year":"2019","unstructured":"Ling L, Feng X, Wei T, Wang Y, Wang Y, Wang Z, Tang D, Luo Y, Xiong Z. Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism. Stem Cell Res Ther. 2019;10(1):46.","journal-title":"Stem Cell Res Ther"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-10-56"},{"issue":"1","key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13287-021-02271-3","article-title":"Human placenta mesenchymal stem cell-derived exosomes delay H2O2-induced aging in mouse cholangioids","volume":"12","author":"Chen W","year":"2021","unstructured":"Chen W, Zhu J, Lin F, Xu Y, Feng B, Feng X, Sheng X, Shi X, Pan Q, Yang J, et al. Human placenta mesenchymal stem cell-derived exosomes delay H2O2-induced aging in mouse cholangioids. Stem Cell Res Ther. 2021;12(1):201.","journal-title":"Stem Cell Res Ther"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2016.097"},{"key":"e_1_3_4_40_2","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.907901","article-title":"Highly efficient methods to culture mouse cholangiocytes and small intestine organoids","volume":"13","author":"Chen W","year":"2022","unstructured":"Chen W, Yao Q, Wang R, Fen B, Chen J, Xu Y, Yu J, Li L, Cao H. Highly efficient methods to culture mouse cholangiocytes and small intestine organoids. Front Microbiol. 2022;13: 907901.","journal-title":"Front Microbiol"}],"container-title":["Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T07:02:46Z","timestamp":1702882966000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.34133\/research.0207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":39,"alternative-id":["10.34133\/research.0207"],"URL":"https:\/\/doi.org\/10.34133\/research.0207","relation":{},"ISSN":["2639-5274"],"issn-type":[{"value":"2639-5274","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"2023-01-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"0207"}}